Canada markets closed

Nurix Therapeutics, Inc. (NRIX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.78+0.05 (+0.39%)
At close: 04:00PM EDT
12.78 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 780.44M
Enterprise Value 565.61M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.62
Price/Book (mrq)4.62
Enterprise Value/Revenue 6.99
Enterprise Value/EBITDA -3.96

Trading Information

Stock Price History

Beta (5Y Monthly) 2.06
52-Week Change 338.07%
S&P500 52-Week Change 322.38%
52 Week High 318.12
52 Week Low 34.22
50-Day Moving Average 313.72
200-Day Moving Average 39.48

Share Statistics

Avg Vol (3 month) 31.07M
Avg Vol (10 day) 3956.66k
Shares Outstanding 561.07M
Implied Shares Outstanding 661.07M
Float 839.64M
% Held by Insiders 12.18%
% Held by Institutions 177.31%
Shares Short (Apr 15, 2024) 47.04M
Short Ratio (Apr 15, 2024) 45.18
Short % of Float (Apr 15, 2024) 415.87%
Short % of Shares Outstanding (Apr 15, 2024) 414.32%
Shares Short (prior month Mar 15, 2024) 46.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 30, 2023
Most Recent Quarter (mrq)Feb 29, 2024

Profitability

Profit Margin -178.93%
Operating Margin (ttm)-272.65%

Management Effectiveness

Return on Assets (ttm)-28.80%
Return on Equity (ttm)-65.37%

Income Statement

Revenue (ttm)80.89M
Revenue Per Share (ttm)1.48
Quarterly Revenue Growth (yoy)30.70%
Gross Profit (ttm)N/A
EBITDA -150.9M
Net Income Avi to Common (ttm)-144.73M
Diluted EPS (ttm)-2.66
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)243.99M
Total Cash Per Share (mrq)4.96
Total Debt (mrq)29.16M
Total Debt/Equity (mrq)17.28%
Current Ratio (mrq)2.86
Book Value Per Share (mrq)3.43

Cash Flow Statement

Operating Cash Flow (ttm)-74.86M
Levered Free Cash Flow (ttm)-34.76M